DEPDC-AS1, CCNB1 and CDC20 expressions were classified into low and high expression groups according to the optimal cut-off values; the survival analysis results revealed that the high expression of DEPDC-AS1, CCNB1 and CDC20 was significantly related to poor prognosis in BLCA patients, ROC results showed that the AUC for 1 year of DEPDC-AS1, CCNB1 and CDC20 was 0.56, 0.58 and 0.63, 3 years of DEPDC-AS1, CCNB1 and CDC20 was 0.55, 0.53 and 0.65, of DEPDC-AS1, CCNB1 and CDC20 was 0.57, 0.55 and 0.56 (Figures 5F–H). This evidence concerns the gene CCNB1 and bladder transitional cell carcinoma.